Urinary Tract Infection Bacterial Clinical Trial
— EEStiVeNOfficial title:
Evaluation of the Bladder Stimulation, a Non-invasive Technique of Urine Collection, in Infant Less Than 6 Months to Diagnose Urinary Tract Infection: a Randomized Multicenter Study
Verified date | September 2023 |
Source | Fondation Lenval |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Urinary tract infection (UTI) is the most common serious bacterial infection among infants. Suprapubic aspiration and bladder catheterization are considered as the gold standard by the American Academy of Pediatrics for the diagnosis, yet it is painful and invasive. In contrast, the bladder stimulation technique has been shown to be a quick and non-invasive approach to collect urine in young infants. Actually, the investigators don't have data on bacterial contamination rates for clean-catch midstream urine collections using this technique
Status | Completed |
Enrollment | 170 |
Est. completion date | December 12, 2023 |
Est. primary completion date | December 12, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 6 Months |
Eligibility | Inclusion Criteria: - Infants under the age of 6 months - For whom an urine sample is required for the diagnosis of a urinary tract infection as follows: - fever > 39 °C without symptoms - fever > 38°C and uropathy or urinary tract infection - fever > 38°C and < 3 months - fever > 38 °C and > 48h - fever > 38 °C with sepsis signs - Obtaining the authorization of the holders of parental authority - Affiliation to French social security Exclusion Criteria: - Do exhibiting signs of vital distress (respiratory or circulatory or neurological) - contraindication to bladder catheterization - antibiotic therapy in the last 48 hours - antibiotic prophylaxis in the last 48 hours |
Country | Name | City | State |
---|---|---|---|
France | CH Antibes Juans les Pins | Antibes | |
France | CH Grasse | Grasse | |
France | CHRU Lille | Lille | |
France | Hôpitaux Pédiatriques de Nice CHU-Lenval | Nice |
Lead Sponsor | Collaborator |
---|---|
Fondation Lenval |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bacterial contamination rates of urine samples per bladder stimulation and urinary catheterization | Bacterial contamination of urine sample is defined by:
the growth of two or more micro-organisms, or the presence of a non-uropathogenic germ (lactobacilli, Staphylococcus Coagulase negative, Corynebacterium), or a bacteriuria> 0 colony forming unit(CFU)/ml but <104 CFU / ml for bladder catheterization and <105 CFU / ml for clean catch urine collected by bladder stimulation, or leukocyturia <104 / ml |
at 48 hours after inclusion date | |
Secondary | Pain of bladder stimulation | pain is measured by Evaluation ENfant DOuLeur (EVENDOL) scale while the technique is performed. EVENDOL is a pain scale for children under 7. A pain scale validated for children from birth to 7 years. Score ranges from 0 to 15. Treatment threshold: 4/15. | through intervention completion, an average 30 min | |
Secondary | Pain of bladder catheterization | pain is measured by Evaluation ENfant DOuLeur (EVENDOL) scale while the technique is performed. EVENDOL is a pain scale for children under 7. A pain scale validated for children from birth to 7 years. Score ranges from 0 to 15. Treatment threshold: 4/15. | through intervention completion, an average 30 min | |
Secondary | Diagnostic performance of the dipstick urine test | The diagnostic performance of the urinary dipstick will be established through sensitivity , specificity, positive predictive value and negative predictive value taking as Gold Standard cytobacteriological examination of the urine (ECBU). Diagnostic performance, as well as accuracy, will be established in each of the two groups.
The sensitivity and specificity will be calculated as well as their 95% confidence intervals calculated using the method of the Wilson score |
through intervention completion, an average 30 min | |
Secondary | Risk factors associated with the failure of the bladder stimulation technique | for a urinary sample quantity < 2 ml or no urinary sample collected; potential risk factors for failure will be collected (pain, Wight, sex, age, last food and time since las collect urine) | through intervention completion, an average 30 min |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02543827 -
Evaluation of the Efficacy and Safety of MV140
|
Phase 3 | |
Recruiting |
NCT04291768 -
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
|
Phase 4 | |
Recruiting |
NCT05667207 -
Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)
|
N/A | |
Completed |
NCT04671290 -
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae
|
||
Completed |
NCT03774940 -
Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy
|
N/A | |
Terminated |
NCT04287478 -
Bacteriophage Therapy in Patients With Urinary Tract Infections
|
Phase 1/Phase 2 | |
No longer available |
NCT04173013 -
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
|